The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Fundamentals data is provided by FTSE Russell Data Solutions. To provide comparable issuer data, information has been standardised by FTSE Russell Data Solutions using globally adopted XBRL taxonomies. The data presented may therefore differ from an issuer's annual report and 'as reported' data should be obtained directly from the source issuer.

Data is provided "AS IS", with all faults, and on an "AS AVAILABLE" basis for information purposes only. London Stock Exchange is not liable for any errors, omissions or other defects in the data, or for any decisions taken in reliance of the data. Please see our full disclaimer here:
Income Statement 31-Dec-17
( $ m )
( $ m )
Continuing Operations
Revenue  39.31 97.28
Operating Profit/(Loss)  31.70 74.04
Net Interest  0.00 0.00
Profit Before Tax  31.69 70.15
Profit After Tax  n/a n/a
Discontinued Operations
Profit After Tax  n/a n/a
Attributable to:
Minority Interests  n/a n/a
Equity Holders of Parent Company  31.69 70.15
Continuing EPS
Earnings per Share - Basic  4.13¢ 7.09¢
Earnings per Share - Diluted  4.13¢ 7.09¢
Earnings per Share - Adjusted  n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  4.13¢ 7.09¢
Earnings per Share - Diluted  4.13¢ 7.09¢
Earnings per Share - Adjusted  n/a n/a
Dividend per Share  n/a 18.82¢

Balance Sheet 31-Dec-17
( $ m )
( $ m )
Non-Current Assets
Property, Plant & Equipment  n/a n/a
Intangible Assets  n/a n/a
Investment Properties  n/a n/a
Investments  569.63 1008.25
Other Financial Assets  n/a n/a
Other Non-Current Assets  0.00 0.00
  569.63 1008.25
Current Assets
Inventories  n/a n/a
Trade & Other Receivables  5.04 21.45
Cash at Bank & in Hand  350.82 363.57
Current Asset Investments  n/a n/a
Other Current Assets  0.00 0.00
  355.86 385.02
Total Assets  925.49 1393.27
Current Liabilities
Borrowings  n/a n/a
Other Current Liabilities  0.33 0.02
  2.92 5.46
Net Current Assets  352.94 379.56
Non-Current Liabilities
Borrowings  0.00 0.00
Provisions  n/a n/a
Other Non-Current Liabilities  n/a 7.79
  n/a 7.79
Other Liabilities  n/a n/a
Total Liabilities  2.92 13.25
Net Assets  922.57 1380.02
Capital & Reserves
Share Capital  9.14 13.74
Share Premium Account  150.38 607.12
Other Reserves  n/a n/a
Retained Earnings  n/a n/a
Shareholders Funds  922.57 1380.02
Minority Interests/Other Equity  n/a n/a
Total Equity *   922.57 1380.02

Ratios - based on IFRS 31-Dec-17 31-Dec-18
Continuing Operations
PE Ratio *   25.18 15.02
PEG *   n/a 0.14
Earnings per Share Growth  n/a 104.12%
Dividend Cover *   n/a 0.38
Revenue Per Share  4.31¢ 9.84¢
Pre-Tax Profit per Share  3.48¢ 7.09¢
Operating Margin  80.63% 76.11%
Return on Capital Employed  n/a 6.43%
Continuing & Discontinued Operations
Dividend Yield *   n/a 17.67%
Dividend per Share Growth  n/a n/a
Net Asset Value per Share (exc. Intangibles)  100.91¢ 100.44¢
Net Gearing *   n/a n/a

Data provided by FTSE Russell


Company Information
Company website
Company address Beaufort House, 51 New North Road, Exeter, EX4 4EP, United Kingdom
FTSE ICB sector -
FTSE ICB subsector -
Company market cap, £m* 1,064.77
Admission date 27 Mar 2017
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index -
Market Main Market - SFS
Market identifier code (MIC) XLON
Trading service SETS
Trading segment SFM1
Listing category -
Country of share register GB
Exchange market size 5,000
Security market cap, £m 1,064.77
*The market capitalisation of the security reflects data from previous trading day.

BIOPHARMA CRED. share fundamentals (BPCR)